Networking Begins In:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Wednesday, March 19th, 2025- Day 2 Main Conference - EST/EDT (Eastern Daylight, GMT-4)
- Alison Fethke - Counsel, Ropes & Gray LLP
- Kaushal Rana - Brand Counsel, Takeda Pharmaceuticals
- Justin Sinchul Kang - Corporate Counsel - Patient Support & Diagnostic Testing, Sanofi
- Doreen Rice - Director, Patient Assistance Programs, AstraZeneca
- Adam Boenning - Associate Director, BBU Commercial Compliance, AstraZeneca
Gain a comprehensive overview of the uninsured population, including demographics, geographic distribution and common health conditions
Address common challenges faced by patients in accessing PAPs, such as language barriers, transportation issues and lack of awareness
Understand what the role of programs in accessing PAPs vs. accessing the healthcare system as a whole
- Aaron Winn - Associate Professor, University of Chicago
This session explores how patient support and assistance professionals can play a pivotal role in reducing health disparities by understanding key Social Determinants of Health (SDOH) and connecting underserved patients to critical resources. By addressing challenges on an individual level, patient support teams can make a meaningful impact on healthcare access and outcomes.
Gain insights into the Social Determinants of Health and their impact on patient access to care
Learn practical approaches for addressing health disparities at both societal and individual levels
Discover resources and services available to help underserved patients overcome healthcare barriers
- Matt Toresco - Founder & Editor-In-Chief, Archo Advocacy
- John Hoffman - Principal, Advocate for Access, LLC
Understand the strategic shifts within organizations when an organization decides to create its own PAP foundation outside of its core business
Explore the motivations behind the decision, including the benefits of independence, such as enhanced regulatory compliance and greater flexibility in program design
Learn about the challenges of establishing and managing an independent foundation, from legal considerations to ensuring effective patient support and maintaining brand integrity
Gain insight on how to educate business stakeholders on our foundations
- Rachel Thorpe - Executive Director, Otsuka Patient Assistance Foundation, Inc.
The World Health Organization projects a global shortfall of 10 million health workers by 2030, and the pharmaceutical industry is not immune. Much of the focus has been on clinicians, but this threat also extends to those in operational roles in pharma. That’s a problem, as the fragmented nature of the US healthcare system means these teams play a vital role in patient access and medication adherence. In this session, Infinitus Co-founder and Company Lead Ankit Jain will share never-before-seen data that illuminates the scope of workforce challenges in the industry – and most importantly, he’ll explore how patient access programs can fortify themselves by building a network of AI agents to work alongside their human teams.
- Ankit Jain - Founder & Company Lead, Infinitus
Gain insights into how various organizations have adapted their programs in response to the IRA, including strategic shifts and operational adjustments
Explore the ramifications for drugs excluded from the IRA, including market access challenges and shifts in patient access
Learn key strategies for anticipating and adapting to future legislative changes, ensuring resilience and alignment with regulatory developments
Monitor potential downstream unexpected impacts such as payer restrictions in the commercial space
- Joshua Walsh - Director of Patient Access, Abbvie
- Judd Caulfield - Lead Counsel, Oncology Business Unit, Takeda Pharmaceuticals
Stay informed about federal and state laws that govern the collection, use and disclosure of patient data
Implement effective measures to protect patient information from unauthorized access, breaches and misuse
Explore the legal, reputational and financial risks associated with data breaches and how to prevent them
- Tina Olson Grande, MHS - President and CEO, Healthcare Trust Institute
Define programs’ roles in helping patients understand their coverage offerings, cost responsibility and long-term affordability
Understand the status of patient and health literacy across key populations, looking specifically at the digital divide
Gain insight on how patients are utilizing translation services
Understand the role of patient navigators in reaching and engaging with patients
- Kristen Willard - Vice President of Education, Global Allergy & Airways Patient Platform (GAAPP)
Discover how artificial intelligence is reshaping patient support programs, beyond traditional personas and business rules. This session will explore innovative uses of AI, focusing on how it can be leveraged to enhance the effectiveness and efficiency of patient communications. Attendees will examine whether current technology is meeting industry expectations and discuss how AI further optimizes patient support programs to improve therapy initiation and adherence.
- William Grambley - CEO, AllazoHealth
- Bridget Wills - Senior Director, Marketing and Communications, AssistRX
- Jackie Britt - Vice President, Strategic Account Management, AssistRx
- Kelley Winfield - Senior Director, Market Access, pharma&
- Rachel Shephard Robinson - Senior Manager, Patient Access, pharma&
- Rebecca Leemputte - Associate Partner, The Dedham Group
This session explores the critical issue of medical debt and financial toxicity, focusing on both policy solutions that can support patients in the long-term, and practical strategies to support patients right now. Attendees will learn how case management teams are actively working with patients to navigate financial challenges, including negotiating down bills, and offering financial assistance.
- Discuss the importance of bringing more of these services in-house and expanding the role of case management to better prevent, protect, and empower patients
- Highlight the collaboration between case management teams and policy and advocacy offices, emphasizing the need for laws and regulations that protect patients
- Brian Connell - Executive Director of Federal Gov’t Affairs, Office of Public Policy, The Leukemia & Lymphoma Society
- Ryan Holeywell - Executive Director, Mission Communications, The Leukemia & Lymphoma Society
Explore strategies to effectively educate patients on their healthcare rights, benefits and available options
Assess patient engagement with their disease and identify opportunities for improvement
Discuss methods to enhance patient empowerment beyond the focus on product or disease state
Consider innovative approaches to fostering a more patient-centric healthcare journey
- Rachel Thorpe - Executive Director, Otsuka Patient Assistance Foundation, Inc.
- Kerry Quinn - Associate Principal, ZS
- Discover how comprehensive solutions are transforming pharmaceutical access programs (PAP) across the healthcare value chain
- Explore a suite of solutions including:
- Pharmaceutical Access Programs (PAP)
- Revenue Cycle Management (RCM)
- Benefit Verification (BV), Prior Authorization (PA)
- Learn to leverage upstream and downstream capabilities to optimize patient access and affordability
- Gain insights into data utilization for strategic enhancements
- Understand the necessity of direct connectivity for efficient submissions and results
- Explore methods to catch patients falling outside manufacturer programs
- Coordinate effectively with manufacturers for improved patient services
- Joe Vadakara - Senior Director Health Systems Patient Access, Cencora
- Gemi Bryant - Director, Customer Solutions Global Pharma Services, Cencora
- Lisa Tabel - Director, Patient Assistance, Cencora
- Melissa Paige - President and Co-Founder, National Association of Medication Access & Patient Advocacy
Digitizing and personalizing the patient experience is table stakes for patient support programs yet remains difficult to execute. In this session, we will look at how many reputable pharmaceutical brands are effectively using digital tools to engage patients through every phase of their patient journey, ultimately driving better outcomes. Using insights from 34 use cases across 7 therapeutic areas, the session will detail the use cases that move the needle, those that do not, and benchmarks for levels of engagement.
- Oliver Dunford - Vice President, Life Sciences, Relay Network
As technology reshapes patient support, organizations must navigate both its transformative potential and emerging complexities. This session will showcase a fully integrated, intelligent patient ecosystem in action—demonstrating how AI-driven insights, enhanced control, and streamlined processes empower every role. Learn how to harness these innovations to maximize efficiency and create deeper, more meaningful patient connections.
- Daniel Ogletree - Principal, ZS